Document Detail

Serum concentration of D-dimers as a marker of the activation of the fibrinolytic system in patients undergoing bronchoscopic and thoracoscopic investigations.
MedLine Citation:
PMID:  12740513     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Hypercoagulability is common even after minimally invasive surgical techniques and is pathogenetically linked to postoperative thrombotic and cardiac complications. The activation of the coagulation and fibrinolytic systems after bronchoscopic and thoracoscopic investigations has not yet been elucidated. OBJECTIVE: The aim of our study was to evaluate whether bronchoscopic and thoracoscopic investigations activate the fibrinolytic system. METHODS: This study assessed cross-linked fibrinogen degradation products (D-dimer) in 120 patients after bronchoscopy with and without biopsies and/or bronchoalveolar lavage and after thoracoscopy with biopsies of the parietal pleura. RESULTS: Both bronchoscopy and thoracoscopy induced a minor but significant increase in D-dimers in most patients, reversible mostly within 24 h. In rare cases, distinct increases lasting at least 24 h occurred. CONCLUSIONS: The slight and temporary increase in serum D-dimers induced by bronchoscopy and thoracoscopy is nonsignificant in most patients; however, in some cases, the coagulation/fibrinolytic systems may become markedly activated.
J Schreiber; J Knolle; R Lüdicke; G Florschütz; W Rosahl
Related Documents :
19686413 - Protein c and d-dimer are related to portal vein thrombosis in patients with liver cirr...
12740513 - Serum concentration of d-dimers as a marker of the activation of the fibrinolytic syste...
6864273 - Collagen deficiency and ruptured cerebral aneurysms. a clinical and biochemical study.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Respiration; international review of thoracic diseases     Volume:  70     ISSN:  0025-7931     ISO Abbreviation:  Respiration     Publication Date:    2003 Mar-Apr
Date Detail:
Created Date:  2003-05-12     Completed Date:  2003-09-03     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0137356     Medline TA:  Respiration     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  161-5     Citation Subset:  IM    
Copyright Information:
Copyright 2003 S. Karger AG, Basel
Department of Pulmonology, Municipal Hospital of Dessau, Dessau, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antifibrinolytic Agents / analysis*
Biological Markers / analysis*
Fibrin Fibrinogen Degradation Products / analysis*
Fibrinolysis / physiology*
Reg. No./Substance:
0/Antifibrinolytic Agents; 0/Biological Markers; 0/Fibrin Fibrinogen Degradation Products; 0/fibrin fragment D

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Increased vitronectin and endothelin-1 in the breath condensate of patients with fibrosing lung dise...
Next Document:  Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophil...